Hans van der Boom

1.4k citations

23 papers · 1.2k indexed · h-index 17

Surgery top 5%
Molecular Biology
Endocrinology, Diabetes and Metabolism top 5%
Cardiology and Cardiovascular Medicine top 10%
Immunology

Co-authors: Louis M. Havekes Marten H. Hofker Rune R. Frants Arn M. J. M. van den Maagdenberg Marion J. Gijbels Bart J. van Vlijmen Theo J.C. van Berkel Miek C. Jong
Topics: Cancer, Lipids, and Metabolism (9 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers)Lipoproteins and Cardiovascular Health (8 papers)
Cited by: Endocrinology, Diabetes and Metabolism Surgery Biochemistry
Journals: Journal of Biological Chemistry Circulation Journal of Clinical Investigation
Partner nations: Netherlands Japan United States

In The Last Decade

Hans van der Boom

23 papers receiving 1.2k citations

Peers

Countries citing papers authored by Hans van der Boom

Since Specialization

Citations

This map shows the geographic impact of Hans van der Boom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans van der Boom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans van der Boom more than expected).

Fields of papers citing papers by Hans van der Boom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans van der Boom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans van der Boom. The network helps show where Hans van der Boom may publish in the future.

Co-authorship network of co-authors of Hans van der Boom

This figure shows the co-authorship network connecting the top 25 collaborators of Hans van der Boom. A scholar is included among the top collaborators of Hans van der Boom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans van der Boom. Hans van der Boom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rosuvastatin Reduces Plasma Lipids by Inhibiting VLDL Production and Enhancing Hepatobiliary Lipid Excretion in ApoE3-Leiden Mice 2004 ·Journal of Cardiovascular Pharmacology* ·Dianne J. Delsing,Sabine M. Post,Martine Groenendijk,Karianne Solaas,Hans van der Boom,Wim van Duyvenvoorde,E.C.M. de Wit,Vincent W. Bloks,Folkert Kuipers,Louis M. Havekes,P. Hans	17
2	Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus 2004 ·Neurobiology of Disease ·Monique Mulder,Paula J. Jansen,Ben Janssen,Wilma D. J. van de Berg,Hans van der Boom,Louis M. Havekes,E. R. de Kloet,Frans C. S. Ramaekers,Arjan Blokland	79
3	Stimulation of the in Vivo Production of Very Low Density Lipoproteins by Apolipoprotein E Is Independent of the Presence of the Low Density Lipoprotein Receptor 2001 ·Journal of Biological Chemistry ·Bas Teusink,Arjen R. Mensenkamp,Hans van der Boom,Folkert Kuipers,Ko Willems van Dijk,Louis M. Havekes	18
4	Food Choice in Hyperthyroidism: Potential Influence of the Autonomic Nervous System and Brain Serotonin Precursor Availability 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Hanno Pijl,Paul H. E. Meijer,J.A.E. Langius,(unknown),(unknown),Prataap K. Chandie Shaw,Hans van der Boom,Rik C. Schoemaker,(unknown),Jacobus Burggraaf,A. Edo Meinders	45
5	Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice 2001 ·Journal of Lipid Research ·Miek C. Jong,Patrick C.N. Rensen,Vivian E.H. Dahlmans,Hans van der Boom,Theo J.C. van Berkel,Louis M. Havekes	124
6	Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo 2000 ·Journal of Biological Chemistry ·Patrick C.N. Rensen,Miek C. Jong,(unknown),Hans van der Boom,(unknown),Theo J.C. van Berkel,Erik A.L. Biessen,Louis M. Havekes	66
7	New HMG-CoA reductase inhibitor ZD4522 lowers plasma lipids and VLDL production in APOE3Leiden transgenic mice 2000 ·Atherosclerosis* ·L.M. Havekes,Hans van der Boom,J.J. Emeis,P. Hans	4
8	Effects of amlodipine and atorvastatin on the development of atherosclerosis in ApoE3-Leiden transgenic mice 2000 ·Atherosclerosis* ·Dianne J. Delsing,J. Wouter Jukema,Hans van der Boom,Erik H. Offerman,Arnoud van der Laarse,Louis M. Havekes,P. Hans	1
9	Hyperlipidemia of ApoE2(Arg ₁₅₈ -Cys) and ApoE3-Leiden Transgenic Mice Is Modulated Predominantly by LDL Receptor Expression 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ko Willems van Dijk,Bart J.M. van Vlijmen,Menno P.J. de Winther,(unknown),André van der Zee,Hans van der Boom,Louis M. Havekes,Marten H. Hofker	10
10	Reversal of Hypercholesterolemia in Apolipoprotein E2 and Apolipoprotein E3-Leiden Transgenic Mice by Adenovirus-Mediated Gene Transfer of the VLDL Receptor 1998 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ko Willems van Dijk,Bart J.M. van Vlijmen,André van der Zee,(unknown),Hans van der Boom,Kunihisa Kobayashi,Lawrence Chan,Louis M. Havekes,Marten H. Hofker	21
11	In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E3-Leiden Transgenic Mice 1996 ·Journal of Biological Chemistry ·Bart J.M. van Vlijmen,Ko Willems van Dijk,(unknown),Patrick J. van Gorp,André van der Zee,Hans van der Boom,Marco L. Breuer,Marten H. Hofker,Louis M. Havekes	45
12	Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. 1996 ·Journal of Clinical Investigation ·Bart J. van Vlijmen,(unknown),M.J.T.M. Mol,Hans van der Boom,Anke H. Maitland‐van der Zee,Rune R. Frants,Marten H. Hofker,Louis M. Havekes	76
13	Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages 1996 ·Biochemical Journal ·(unknown),Hans van der Boom,(unknown),Louis M. Havekes	53
14	Increased response to cholesterol feeding in apolipoprotein C1-deficient mice 1995 ·Biochemical Journal ·Janine H. van Ree,Marten H. Hofker,Walther J. A. A. van den Broek,Jan M. A. van Deursen,Hans van der Boom,Rune R. Frants,Bé Wieringa,Louis M. Havekes	39
15	Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins 1994 ·Atherosclerosis ·Monique Mulder,Hans van der Boom,Peter de Knijff,(unknown),Arn M. J. M. van den Maagdenberg,J.A. Gevers Leuven,Louis M. Havekes	15
16	Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. 1994 ·Journal of Clinical Investigation ·Bart J. van Vlijmen,Arn M. J. M. van den Maagdenberg,Marion J. Gijbels,Hans van der Boom,Harm HogenEsch,Rune R. Frants,Marten H. Hofker,Louis M. Havekes	214
17	Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia 1993 ·Journal of Biological Chemistry ·Arn M. J. M. van den Maagdenberg,Marten H. Hofker,Paul Krimpenfort,Ino de Bruijn,Bas van Vlijmen,Hans van der Boom,Louis M. Havekes,Rune R. Frants	192
18	Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. 1993 ·Journal of Biological Chemistry ·Pietro Lombardi,Monique Mulder,Hans van der Boom,(unknown),Louis M. Havekes	28
19	Visualization of the interaction of native and modified lipoproteins with parenchymal, endothelial and Kupffer cells from human liver 1991 ·Hepatology ·(unknown),Hans van der Boom,Donald Schouten,Paul Roholl,(unknown),Adriaan Brouwer,Theo J.C. van Berkel,Dick Knook	23
20	Molecular aspects of age-related changes in albumin synthesis in female WAG/Rij rats 1988 ·Life Sciences ·G. Jean Horbach,Hans van der Boom,(unknown),Sing Hiem Yap	3

About Hans van der Boom

Hans van der Boom is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (310 citations), Surgery (598 citations) and Biochemistry (91 citations). Hans van der Boom has collaborated with scholars based in Netherlands, Japan and United States. Frequent co-authors include Louis M. Havekes, Marten H. Hofker, Rune R. Frants, Arn M. J. M. van den Maagdenberg, Marion J. Gijbels, Bart J. van Vlijmen, Theo J.C. van Berkel, Miek C. Jong, Patrick C.N. Rensen and Harm HogenEsch. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact